Form 4: Nuveen VP Plans Future Stock Sale Under 10b5-1 Plan
Insider Transaction Report
Nuveen Floating Rate Income Fund Vice President David J. Lamb reported a future sale of 4,000 shares of common stock at $7.84 per share under a Rule 10b5-1 plan.
Summary
- David J. Lamb, Vice President of Nuveen Floating Rate Income Fund (JFR), reported a planned future sale of common stock.
- The transaction involves the disposition of 4,000 shares of common stock.
- The shares are planned to be sold at a price of $7.84 per share.
- The sale is scheduled to occur on December 30, 2025.
- Following this planned transaction, David J. Lamb will beneficially own 18,338 shares of common stock directly.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: A neutral score. While an insider sale can be seen negatively, the execution under a Rule 10b5-1 plan and the future transaction date mitigate immediate concerns about new negative information. It's a routine disclosure for a pre-planned future transaction.
Positives
- The transaction is executed under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than an immediate reaction to new, non-public information, which can reduce concerns about insider trading.
Negatives
- An officer planning to sell shares, even under a 10b5-1 plan, can sometimes be perceived as a signal regarding their long-term confidence in the company's future prospects, though this is mitigated by the pre-planned nature and future date.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the planned insider transaction itself.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. Insider sales, even under 10b5-1 plans, are routinely monitored by investors for insights into management's perspective on valuation, though a future-dated transaction has less immediate impact.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | David Lamb granted Power of Attorney to Kevin J. McCarthy, Christopher M. Rohrbacher, and Mark L. Winget to execute Forms 3, 4, and 5 on his behalf for Nuveen Investments Closed-End Funds. | 2021-06-22 | This streamlines the process for timely filing of insider transaction reports, ensuring compliance with Section 16(a) of the Securities Exchange Act of 1934 and Section 30(f) of the Investment Company Act of 1940. |
Stakeholder Impact
- Shareholders: May interpret the planned future sale as a signal, though the 10b5-1 plan and distant transaction date suggest it is not based on new, immediate information and is a routine part of personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 2021-06-22 | Date Power of Attorney was executed by David Lamb, granting authority to others for SEC filings. |
| 2025-12-30 | Date of the planned transaction (sale of common stock). |
| 2026-01-02 | Date the Form 4 was signed by Mark L. Winget under Power of Attorney. |
Recommendation
holdThe reported transaction is a routine insider sale planned for a future date (December 2025) and executed under a Rule 10b5-1 plan. This typically indicates a pre-scheduled disposition rather than a reaction to new material non-public information. Given the distant future date and the pre-planned nature, this single transaction does not provide sufficient grounds for an immediate 'buy' or 'sell' recommendation, thus a 'hold' is appropriate as it is unlikely to significantly impact the stock price in the short term.
Keywords
Nuveen Floating Rate Income Fund, JFR, Insider Transaction, Form 4, Stock Sale, David J. Lamb, Rule 10b5-1, Officer Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.